Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Jun;48(3):658–663. doi: 10.1128/iai.48.3.658-663.1985

Immunization against experimental murine salmonellosis with liposome-associated O-antigen.

J V Desiderio, S G Campbell
PMCID: PMC261222  PMID: 2581898

Abstract

Partially delipidated Salmonella typhimurium (O-1,4,5,12) lipopolysaccharide was incorporated into small multilamellar liposomes composed of either naturally occurring or synthetic phospholipids. Vaccination of mice with the liposome-lipopolysaccharide complexes induced a cellular response specific for O-1,4,5,12 determinants, as determined by the development of a delayed-type hypersensitivity reaction. The liposome-lipopolysaccharide vaccines were significantly more effective, compared with other nonviable vaccines tested, in protecting mice against a lethal intravenous challenge infection with virulent S. typhimurium. Protection afforded by the liposome-lipopolysaccharide vaccines was comparable to that conferred by a live S. typhimurium vaccine. Results suggest that liposome-induced modulation of the host immune response in favor of cell-mediated immunity may be more efficacious in preventing diseases in which cell-mediated immunity is of prime importance.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. G., Gregoriadis G. Liposomes as immunological adjuvants. Nature. 1974 Nov 15;252(5480):252–252. doi: 10.1038/252252a0. [DOI] [PubMed] [Google Scholar]
  2. Almeida J. D., Edwards D. C., Brand C. M., Heath T. D. Formation of virosomes from influenza subunits and liposomes. Lancet. 1975 Nov 8;2(7941):899–901. doi: 10.1016/s0140-6736(75)92130-3. [DOI] [PubMed] [Google Scholar]
  3. Angerman C. R., Eisenstein T. K. Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers. Infect Immun. 1980 Feb;27(2):435–443. doi: 10.1128/iai.27.2.435-443.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blanden R. V., Mackaness G. B., Collins F. M. Mechanisms of acquired resistance in mouse typhoid. J Exp Med. 1966 Oct 1;124(4):585–600. doi: 10.1084/jem.124.4.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Collins F. M., Campbell S. G. Immunity to intracellular bacteria. Vet Immunol Immunopathol. 1982 Jan;3(1-2):5–66. doi: 10.1016/0165-2427(82)90031-9. [DOI] [PubMed] [Google Scholar]
  6. Collins F. M. Effect of specific immune mouse serum on the growth of Salmonella enteritidis in mice preimmunized with living or ethyl alcohol-killed vaccines. J Bacteriol. 1969 Feb;97(2):676–683. doi: 10.1128/jb.97.2.676-683.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Collins F. M., Mackaness G. B., Blanden R. V. Infection-immunity in experimental salmonellosis. J Exp Med. 1966 Oct 1;124(4):601–619. doi: 10.1084/jem.124.4.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collins F. M., Mackaness G. B. Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol. 1968 Nov;101(5):830–845. [PubMed] [Google Scholar]
  9. Collins F. M. Mechanisms in antimicrobial immunity. J Reticuloendothel Soc. 1971 Jul;10(1):58–99. [PubMed] [Google Scholar]
  10. Collins F. M. Vaccines and cell-mediated immunity. Bacteriol Rev. 1974 Dec;38(4):371–402. doi: 10.1128/br.38.4.371-402.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coon J., Hunter R. Selective induction of delayed hypersensitivity by a lipid conjugated protein antigen which is localized in thymus dependent lymphoid tissue. J Immunol. 1973 Jan;110(1):183–190. [PubMed] [Google Scholar]
  12. Eisenstein T. K., Sultzer B. M. Immunity to Salmonella infection. Adv Exp Med Biol. 1983;162:261–296. doi: 10.1007/978-1-4684-4481-0_26. [DOI] [PubMed] [Google Scholar]
  13. Johns M., Skehill A., McCabe W. R. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis. 1983 Jan;147(1):57–67. doi: 10.1093/infdis/147.1.57. [DOI] [PubMed] [Google Scholar]
  14. Kramp W. J., Six H. R., Drake S., Kasel J. A. Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines. Infect Immun. 1979 Aug;25(2):771–773. doi: 10.1128/iai.25.2.771-773.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. LeGrue S. J. Carrier and adjuvant properties of liposome-borne tumor-specific antigens. Cancer Immunol Immunother. 1984;17(2):135–141. doi: 10.1007/BF00200050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lindberg A. A., Holme T. Evaluation of some extraction methods for the preparation of bacterial lipopolysaccharides for structural analysis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(5):751–759. doi: 10.1111/j.1699-0463.1972.tb00203.x. [DOI] [PubMed] [Google Scholar]
  18. Mackaness G. B., Blanden R. V., Collins F. M. Host-parasite relations in mouse typhoid. J Exp Med. 1966 Oct 1;124(4):573–583. doi: 10.1084/jem.124.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mackaness G. B. Resistance to intracellular infection. J Infect Dis. 1971 Apr;123(4):439–445. doi: 10.1093/infdis/123.4.439. [DOI] [PubMed] [Google Scholar]
  20. Mackaness G. B. The relationship of delayed hypersensitivity to acquired cellular resistance. Br Med Bull. 1967 Jan;23(1):52–54. doi: 10.1093/oxfordjournals.bmb.a070516. [DOI] [PubMed] [Google Scholar]
  21. Manesis E. K., Cameron C. H., Gregoriadis G. Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett. 1979 Jun 1;102(1):107–111. doi: 10.1016/0014-5793(79)80939-4. [DOI] [PubMed] [Google Scholar]
  22. Nickol A. D., Bonventre P. F. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines. J Med Microbiol. 1981 Nov;14(4):419–433. doi: 10.1099/00222615-14-4-419. [DOI] [PubMed] [Google Scholar]
  23. Ornellas E. P., Roantree R. J., Steward J. P. The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella. J Infect Dis. 1970 Feb;121(2):113–123. doi: 10.1093/infdis/121.2.113. [DOI] [PubMed] [Google Scholar]
  24. Parish C. R. Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes. Eur J Immunol. 1972 Apr;2(2):143–151. doi: 10.1002/eji.1830020210. [DOI] [PubMed] [Google Scholar]
  25. Parish C. R. The relationship between humoral and cell-mediated immunity. Transplant Rev. 1972;13:35–66. doi: 10.1111/j.1600-065x.1972.tb00059.x. [DOI] [PubMed] [Google Scholar]
  26. Richardson E. C., Banerji B., Seid R. C., Jr, Levin J., Alving C. R. Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes. Infect Immun. 1983 Mar;39(3):1385–1391. doi: 10.1128/iai.39.3.1385-1391.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Roantree R. J. Salmonella O antigens and virulence. Annu Rev Microbiol. 1967;21:443–466. doi: 10.1146/annurev.mi.21.100167.002303. [DOI] [PubMed] [Google Scholar]
  28. Robertsson J. A., Svenson S. B., Lindberg A. A. Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun. 1982 Aug;37(2):737–748. doi: 10.1128/iai.37.2.737-748.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ryman B. E., Tyrrell D. A. Liposomes--bags of potential. Essays Biochem. 1980;16:49–98. [PubMed] [Google Scholar]
  30. Schroit A. J., Key M. E. Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens. Immunology. 1983 Jul;49(3):431–438. [PMC free article] [PubMed] [Google Scholar]
  31. Segal A. W., Wills E. J., Richmond J. E., Slavin G., Black C. D., Gregoriadis G. Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol. 1974 Aug;55(4):320–327. [PMC free article] [PubMed] [Google Scholar]
  32. Siddiqui W. A., Taylor D. W., Kan S. C., Kramer K., Richmond-Crum S. M., Kotani S., Shiba T., Kusumoto S. Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. Science. 1978 Sep 29;201(4362):1237–1239. doi: 10.1126/science.99814. [DOI] [PubMed] [Google Scholar]
  33. Svenson S. B., Lindberg A. A. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun. 1981 May;32(2):490–496. doi: 10.1128/iai.32.2.490-496.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Svenson S. B., Nurminen M., Lindberg A. A. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun. 1979 Sep;25(3):863–872. doi: 10.1128/iai.25.3.863-872.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Unanue E. R., Feldman J. D. Role of macrophages in delayed hypersensitivity. I. Induction with macrophage-bound antigen. Cell Immunol. 1971 Jun;2(3):269–274. doi: 10.1016/0008-8749(71)90046-3. [DOI] [PubMed] [Google Scholar]
  36. Unanue E. R. The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol. 1981;31:1–136. doi: 10.1016/s0065-2776(08)60919-0. [DOI] [PubMed] [Google Scholar]
  37. van Rooijen N., van Nieuwmegen R., Kors N. The secondary immune response against liposome associated antigens. Immunol Commun. 1981;10(1):59–70. doi: 10.3109/08820138109050687. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES